ASSET | DATE | % RETURN |
---|---|---|
Applied Digital (APLD) | 4/1/2023 - 5/30/2023 | 306.61% |
P3 Health Partners (PIII) | 4/1/2023 - 5/30/2023 | 270.18% |
Nano X Imaging (NNOX) | 4/1/2023 - 5/30/2023 | 196.18% |
Bioventus (BVS) | 4/1/2023 - 5/30/2023 | 166.97% |
Verastem (VSTM) | 4/1/2023 - 5/30/2023 | 147.62% |
Ads Tec Energy (ADSE) | 4/1/2023 - 5/30/2023 | 128.41% |
National CineMedia (NCMI) | 4/1/2023 - 5/30/2023 | 118.89% |
Bit Digital (BTBT) | 4/1/2023 - 5/30/2023 | 112.34% |
Eyepoint Pharmaceuticals (EYPT) | 4/1/2023 - 5/30/2023 | 99.32% |
American Coastal Insurance (ACIC) | 4/1/2023 - 5/30/2023 | 86.6% |
Evolv Technologies (EVLV) | 4/1/2023 - 5/30/2023 | 81.55% |
Organogenesis (ORGO) | 4/1/2023 - 5/30/2023 | 80.95% |
Sana Biotechnology (SANA) | 4/1/2023 - 5/30/2023 | 80.12% |
SEALSQ (LAES) | 4/1/2023 - 5/30/2023 | 74.53% |
Pulse Biosciences (PLSE) | 4/1/2023 - 5/30/2023 | 74.05% |
Autolus Therapeutics (AUTL) | 4/1/2023 - 5/30/2023 | 71.66% |
Arteris (AIP) | 4/1/2023 - 5/30/2023 | 71.63% |
MiMedx (MDXG) | 4/1/2023 - 5/30/2023 | 69.71% |
Microvision (MVIS) | 4/1/2023 - 5/30/2023 | 67.04% |
Akebia Ther (AKBA) | 4/1/2023 - 5/30/2023 | 66.95% |
Terawulf (WULF) | 4/1/2023 - 5/30/2023 | 65.26% |
Phathom Pharmaceuticals (PHAT) | 4/1/2023 - 5/30/2023 | 62.16% |
Jiayin (JFIN) | 4/1/2023 - 5/30/2023 | 61.26% |
Arlo Technologies (ARLO) | 4/1/2023 - 5/30/2023 | 59.93% |
Ideaya Biosciences (IDYA) | 4/1/2023 - 5/30/2023 | 59.21% |